Evaluation of Febrile Seizures: A Therapeutic Review of Current Modalities

Area of Science:

• Pediatrics
• Neurology

Background:

• Febrile seizures (FS) are common in children aged 6 months to 5 years, often causing parental distress.
• Despite their generally benign nature, FS can recur, highlighting a need for better understanding and management.
• Distinguishing between simple and complex febrile seizures (CFS) is crucial, as CFS is associated with higher recurrence rates.

Purpose of the Study:

• To evaluate current therapeutic options for febrile seizures (FS).
• To summarize recent recommendations for managing FS in pediatric patients.
• To assess the effectiveness of current pharmacotherapy for FS.

Main Methods:

• A literature review was conducted using MeSH terms 'seizures, febrile/drug therapy' and 'seizures, febrile/therapy'.
• Keywords yielded 867 results, from which 21 relevant articles were selected for analysis.
• Diagnostic investigations including CT, MRI, and EEG were reviewed for their role in ruling out other causes of seizures.

Main Results:

• Complex febrile seizures (CFS) are more likely to recur than simple FS.
• Diagnostic imaging and laboratory tests are important for differential diagnosis.
• The effectiveness of current pharmacotherapy for FS requires further evaluation based on the reviewed literature.

Conclusions:

• Current pharmacotherapy's effectiveness in treating febrile seizures (FS) warrants further investigation.
• Accurate diagnosis and classification of FS are essential for appropriate management and prognosis.
• Addressing knowledge discrepancies in FS management is vital for improving patient care and parental support.